ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice

Lin, Qianyun; Li, Zitong; Lu, Lei; Xu, Hua; Lou, Eddie; Chen, Alyssa; Sun, Dustin; Zhang, Wuyi; Zhu, Weishu; Yee, Eric U.; Sears, Pamela Suzanne; Chen, Xinhua*; Kelly, Ciaran P.*南方医科大学
Biomedicine and Pharmacotherapy2023-11DOI: 10.1016/j.biopha.2023.115489
6阅读
引用收藏
分享

摘要

Background and aims: Clostridioides difficile infection (CDI) induces intense acute inflammatory responses through toxin release. A combination of antibiotic and anti-inflammatory agents is sometimes recommended in severe, non-responsive cases, although clinical trials have been inconclusive, raising concerns about potential complications. This study aims to investigate the effect of budesonide and mesalamine in the treatment of CDI in a murine model, by evaluating the combination of fidaxomicin and these anti-inflammatory drugs.Method: C57BL/6 J female mice pretreated with an antimicrobial mixture were challenged with C. difficile VPI 10463 or culture media by gavage. After the challenge, mice received placebo, fidaxomicin alone (20 mg/kg), or fidaxomicin combined with mesalamine (200, 400 mg/kg) or budesonide (0.2, 1, 10 mg/kg) for 5 days. The mice were monitored for 7 days with weight and survival. Colon and cecum tissues were harvested for histological assessment.Results: CDI of mice caused 80% mortality. Fidaxomicin completely protected against CDI in all parameters (weight, survival and pathscores). Mortality rates were up to 90%, 70% in budesonide(10 mg/kg) and mesalamine (400 mg/kg) treatment group, respectively. Budesonide (0.02,0.1 and 1 mg/kg) adjunction to fidaxomicin worsened the disease outcome according to all tested parameters. While mesalamine in combination with fidaxomicin (200, 400 mg/kg) did not lead to any deaths during CDI treatment, it did not provide additional benefits.Conclusions: Anti-inflammatory drugs including corticosteroid therapy may worsen the incidence and severity of CDI in this mouse model. These studies may have important clinical implications for understanding the role of anti-inflammatory/ corticosteroid therapy in CDI and inflammatory bowel disease management.

学科与关键词

关键词
C. difficileFidaxomicinBudesonideMesalamine
相关
加载中…
  • Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice
    Wang, Siqi; Deng, Wenlin; Li, Fang; Xiang, Leyang; Lv, Pinjing; Chen, Ye*Journal of Nutritional Biochemistry, 2023, 111: 109155.被引 9
  • Blockade of T helper 17 cell function ameliorates recurrent Clostridioides difficile infection in mice
    Wang, Siqi; Deng, Wenlin; Li, Fang; Chen, Ye*; Wang, Pu*ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53(10): 1290-1299.被引 4
  • Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway
    Sun, Xiaowei; Chen, Zhenhui; Yu, Lu; Zeng, Weisen; Sun, Boyuan; Fan, Hongying*; Bai, Yang*Frontiers in Pharmacology, 2023, 14: 1205323.
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2023-11
卷期
第 167 卷
页码
115489
DOI
10.1016/j.biopha.2023.115489
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Institutes of Health, National Institute of Allergy and Infectious Diseases [1R01AI116596-01]; National Natural Science Foundation of China [82100570]; Beijing Friendship Hospital [YYZZ202027]; Optimer Pharmaceuticals

作者

  • L

    Lin, Qianyun (第一作者)

    capital med univ

  • L

    Li, Zitong

    southern med univ

查看全部 13 位作者收起作者
  • L

    Lu, Lei

  • X

    Xu, Hua

  • L

    Lou, Eddie

  • C

    Chen, Alyssa

  • S

    Sun, Dustin

  • Z

    Zhang, Wuyi

  • Z

    Zhu, Weishu

  • Y

    Yee, Eric U.

  • S

    Sears, Pamela Suzanne

  • C

    Chen, Xinhua (通讯)

  • K

    Kelly, Ciaran P. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417